Thrombopoietin expands hematopoietic stem cells after transplantation

Journal of Clinical Investigation

Volumn 110, Issue 3, 2002, Pages 389-394

  Fox, Norma ^a   Priestley, Greg ^b   Papayannopoulou, Thalia ^b   Kaushansky, Kenneth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; COLONY FORMING CELL; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOCYTE HOMING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0036330339     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215430     Document Type: Article

References (33)

1. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mp1 ligand
2. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
3. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mp1
4. Molecular cloning and chromosomal localization of the human thrombopoietin gene
5. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mp1 ligand thrombopoietin
6. Thrombopoietin: The primary regulator of platelet production
7. Thrombopoietin (c-mp1 ligand) acts synergistically with erythropoietin, stem cell factor, and IL-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro
8. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional
9. Regulation of platelet activation in vitro by the c-Mp1 ligand, thrombopoietin
10. Modulation of platelet activation in vitro by thrombopoietin
11. Regulators of thrombopoiesis: Their biochemistry and physiology
12. Thrombopoietin: Its biology, purification, and characterization
13. Thrombopoietin, the ligand for the Mp1 receptor, synergizes with steel factor and other early-acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice
14. The effect of thrombopoietim on the proliferation and differentiation of murine hematopoietic stem cells
15. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3
16. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy
17. Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion
18. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mp1
19. Hematopoietic stem cell deficiencies in mice lacking c-Mp1, the receptor for thrombopoietin
20. Role of c-mp1 in early hematopoiesis
21. c-mp1 mutations are the cause of congenital amegakaryocytic thrombocytopenia
22. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion
23. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mp1-deficient mice
24. Homing and trafficking of hemopoietic progenitor cells
25. Bone marrow cell trafficking following intravenous administration
26. Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ-specific but CD44-independent
27. Molecular cloning and characterization of MRL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily
28. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells
29. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation
30. Accelerated reconstitution of platelets and erythrocytes following syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice
31. Phase I study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell transplantation (PBPC)
32. Randomized, double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients (Pts) following autologous bone marrow transplantation (ABMT)
33. Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoprosis